BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 8490963)

  • 1. Physical interaction of the retinoblastoma protein with human D cyclins.
    Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
    Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
    Ewen ME; Sluss HK; Sherr CJ; Matsushime H; Kato J; Livingston DM
    Cell; 1993 May; 73(3):487-97. PubMed ID: 8343202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
    Kato J; Matsushime H; Hiebert SW; Ewen ME; Sherr CJ
    Genes Dev; 1993 Mar; 7(3):331-42. PubMed ID: 8449399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression is regulated by the retinoblastoma protein.
    Müller H; Lukas J; Schneider A; Warthoe P; Bartek J; Eilers M; Strauss M
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2945-9. PubMed ID: 8159685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.
    Horton LE; Qian Y; Templeton DJ
    Cell Growth Differ; 1995 Apr; 6(4):395-407. PubMed ID: 7794807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.
    Connell-Crowley L; Harper JW; Goodrich DW
    Mol Biol Cell; 1997 Feb; 8(2):287-301. PubMed ID: 9190208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.
    Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL
    Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
    Nakayama T; Hashimoto Y; Kaneko Y; Kurokawa K
    Biochem Biophys Res Commun; 1996 Jul; 224(1):180-3. PubMed ID: 8694809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
    Dick FA; Sailhamer E; Dyson NJ
    Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation.
    Skapek SX; Rhee J; Kim PS; Novitch BG; Lassar AB
    Mol Cell Biol; 1996 Dec; 16(12):7043-53. PubMed ID: 8943359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.
    Baker GL; Landis MW; Hinds PW
    Cell Cycle; 2005 Feb; 4(2):330-8. PubMed ID: 15684604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL; Williams RT; Wu L; Wu F; Carbonaro-Hall DA; Harper JW; Warburton D
    Oncogene; 1993 May; 8(5):1377-84. PubMed ID: 8479754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.
    Spitkovsky D; Steiner P; Gopalkrishnan RV; Eilers M; Jansen-Dürr P
    Oncogene; 1995 Jun; 10(12):2421-5. PubMed ID: 7784093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
    Nielsen NH; Emdin SO; Cajander J; Landberg G
    Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
    Kato JY; Sherr CJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11513-7. PubMed ID: 7505440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.